Earnings Call · Q2 FY2022·2022-08-03

Q2 22EPS -14.29%·Rev n/aQ1 22EPS -35.48%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS +14.29%·Rev n/a⚠ consensus missing

CORCEPT THERAPEUTICS INC CORT

Atabak Mokari — Chief Financial Officer

+2.5%1d on move date+1.0% vs SPY3d+2.5%5d+0.4%

Research tier

Behavioral profile computed for this call's speaker on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CORT calls or request research access.

More CORT calls Browse calls Request research access